Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Brain Neoplasms × Sodium Chloride × Clear all

Phase

Phase 3 3 Phase 4 2 Phase 2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Stomatitis 1 Stomach Neoplasms 1 Solid Tumor Refractory to Standard Therapy 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Ototoxicity 1 Mycosis Fungoides 1 Mucositis 1 Mouth Neoplasms 1 Meningioma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Leiomyoma 1 Hodgkin Disease 1 Hearing Loss 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Fatigue 1 Breast Neoplasms 1 Brain Neoplasms 1 Anemia 1

Interventions

Temozolomide 36 Radiotherapy 20 Radiosurgery 20 Cyclophosphamide 11 Radiation 10 Irinotecan 10 Etoposide 10 Magnetic Resonance Spectroscopy 9 Filgrastim 8 Erlotinib Hydrochloride 8 Carboplatin 8 pembrolizumab 7 Surgical Procedures, Operative 7 Carmustine 7 Bevacizumab 7 Vincristine 6 Sorafenib 6 Flucytosine 6 Aminolevulinic Acid 6 temsirolimus 5 sargramostim 5 Topotecan 5 O(6)-benzylguanine 5 Nivolumab 5 Imatinib Mesylate 5 Granulocyte Colony-Stimulating Factor 5 Everolimus 5 cediranib 4 Vorinostat 4 Valproic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03177252 2020-10-22

Scalp block

Washington University School of Medicine

Phase 1 Withdrawn

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡